Cargando…

Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy

AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarma, Mridul Kumar, Missong, Ajit K., Sharma, Moitrayee, Debnath, Asim, Mahanta, Neelakshi, Choudhury, Mrinmoy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485539/
https://www.ncbi.nlm.nih.gov/pubmed/37694015
http://dx.doi.org/10.4103/jpbs.jpbs_196_23
_version_ 1785102810302382080
author Sarma, Mridul Kumar
Missong, Ajit K.
Sharma, Moitrayee
Debnath, Asim
Mahanta, Neelakshi
Choudhury, Mrinmoy M.
author_facet Sarma, Mridul Kumar
Missong, Ajit K.
Sharma, Moitrayee
Debnath, Asim
Mahanta, Neelakshi
Choudhury, Mrinmoy M.
author_sort Sarma, Mridul Kumar
collection PubMed
description AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two groups. Group A was taken up for upfront surgery and group B was taken up for surgery after two to three cycles of NACT based on patients’ response, performance, and compliance. RESULTS: Neither group showed statistically significant differences in clinical characteristics. In the present study, satisfactory outcomes were seen in nine patients belonging to NACT group and eight patients of non-NACT group had satisfactory outcomes after surgery, which were found to be statistically significant (P = 0.001). CONCLUSION: NACT may be considered as a treatment option for oral squamous cell carcinoma patients, particularly those with locally advanced tumors. Further prospective studies are needed to validate these findings in patients.
format Online
Article
Text
id pubmed-10485539
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-104855392023-09-09 Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy Sarma, Mridul Kumar Missong, Ajit K. Sharma, Moitrayee Debnath, Asim Mahanta, Neelakshi Choudhury, Mrinmoy M. J Pharm Bioallied Sci Original Article AIM: The aim of the present study was to compare the treatment outcome in oral cancer cases treated with neoadjuvant chemotherapy (NACT) and upfront surgery in localized advance disease. MATERIALS AND METHODS: A randomized, prospective study was conducted in 20 cases. Patients were divided into two groups. Group A was taken up for upfront surgery and group B was taken up for surgery after two to three cycles of NACT based on patients’ response, performance, and compliance. RESULTS: Neither group showed statistically significant differences in clinical characteristics. In the present study, satisfactory outcomes were seen in nine patients belonging to NACT group and eight patients of non-NACT group had satisfactory outcomes after surgery, which were found to be statistically significant (P = 0.001). CONCLUSION: NACT may be considered as a treatment option for oral squamous cell carcinoma patients, particularly those with locally advanced tumors. Further prospective studies are needed to validate these findings in patients. Wolters Kluwer - Medknow 2023-07 2023-07-11 /pmc/articles/PMC10485539/ /pubmed/37694015 http://dx.doi.org/10.4103/jpbs.jpbs_196_23 Text en Copyright: © 2023 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sarma, Mridul Kumar
Missong, Ajit K.
Sharma, Moitrayee
Debnath, Asim
Mahanta, Neelakshi
Choudhury, Mrinmoy M.
Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title_full Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title_fullStr Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title_full_unstemmed Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title_short Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy
title_sort comparison of post-operative complications in oral cancer treated with and without neoadjuvant chemotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485539/
https://www.ncbi.nlm.nih.gov/pubmed/37694015
http://dx.doi.org/10.4103/jpbs.jpbs_196_23
work_keys_str_mv AT sarmamridulkumar comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy
AT missongajitk comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy
AT sharmamoitrayee comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy
AT debnathasim comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy
AT mahantaneelakshi comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy
AT choudhurymrinmoym comparisonofpostoperativecomplicationsinoralcancertreatedwithandwithoutneoadjuvantchemotherapy